Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
07/2007
07/18/2007EP1807450A2 Broadly cross-reactive hiv-1 neutralizing human monoclonal antibodies
07/18/2007EP1807448A2 Nucleophosmin protein (npm) mutants, corresponding gene sequences and uses thereof
07/18/2007EP1807205A1 A method of antibody purification
07/18/2007EP1806970A1 Milk production method
07/18/2007EP1664343A4 Methods and compositions for generation of germline human antibody genes
07/18/2007EP1664120A4 Antibody specifically binding to sulfonylated protein and method for producing the same
07/18/2007EP1539236A4 Compositions, methods and kits relating to anti-platelet autoantibodies and inhibitors thereof
07/18/2007EP1098905B1 Rna helicases modulating translation termination
07/18/2007EP0860447B1 Hematopoietic stem cell growth factor (scgf)
07/18/2007EP0842949B1 NOVEL MONOCLONAL ANTIBODY AND METHOD OF IMMUNOLOGICAL ANALYSIS OF e-D DIMER AND e-DD/E COMPLEX
07/18/2007CN1327228C Method of identifying N-terminal proBNP
07/18/2007CN1326997C OMPA gene for outer membrane protein of riemerella anatipestifer and methods of use
07/18/2007CN1326881C Trivalent bispecific antibody and its preparation process and use
07/18/2007CN1326880C G-CSF receptor agonist antibodies and screening method therefor
07/18/2007CN1326879C Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same
07/18/2007CN1326878C Anti human non-Hodgkin's lymphoma chimeric antibody and its derivative and application
07/18/2007CN1326877C Specific antibody fragments for the human carcinoembryonic antigen (CEA)
07/18/2007CN1326876C Peptides acting as both GLP-1 receptor agonists and glucagon receptor antagonists and their pharmacological methods of use
07/18/2007CN1326874C SARS coronary virus nail protein high-immune-protosegment, coding sequence and its use
07/18/2007CN1326567C Egg yolk antibody composition for preventing and treating atypical pneumonia and its preparation method
07/18/2007CN1326566C Immunotherapeutic combinations for the treatment of tumors
07/18/2007CN1326565C Potentiator for antibody against lymphoid tumor
07/18/2007CN101001880A Method of treating granuloma annulare or sarcoid
07/18/2007CN101001879A Antibodies binding to CD34+/CD36+ fetal but not to adult cells
07/18/2007CN101001878A Interferon alpha receptor 1 antibodies and their uses
07/18/2007CN101001877A Human monoclonal antibodies against human IL-4
07/18/2007CN101001876A Immunoglobulins comprising predominantly a GlcNacMAN5GLANAC2 glycoform
07/18/2007CN101001875A Immunoglobulins comprising predominantly a man5glcnac2 glycoform
07/18/2007CN101001874A Poly-n-acetyl glucosamine (PNAG/DPNAG)-binding peptides and methods of use thereof
07/18/2007CN101001873A Variant fc regions
07/18/2007CN101001872A Fcgamma-RIIB-specific antibodies and methods of use thereof
07/18/2007CN101001871A Soluble zcytor14, anti-zcytor14 antibodies and binding partners and methods of using in inflammation
07/18/2007CN101001645A Il-17 antagonistic antibodies
07/18/2007CN100999737A Trichina paramyosin gene and application thereof
07/18/2007CN100999732A Process of producing anti-humen CD20 monoclone antibody by animal mammary gland
07/17/2007US7244836 Antitumor agents; antiproliferative agents; antiinflammatory agent
07/17/2007US7244835 Nucleotide sequences coding polypeptide for use in the regulation taste
07/17/2007US7244832 host cell tranformed with a nucleic acid encoding an antibody having a composite heavy chain with a variable domain including complementarity determining regions and framework regions comprising human acceptor antibody heavy chain framework region residues
07/17/2007US7244826 May have a cytotoxin, a label, a radionuclide, a drug, a liposome, a ligand, or an antibody effector attached to the antibody
07/17/2007US7244822 Comprises butyrophilin-like proteins for use in identifying modulator for treatment and prevention inflammatory bowel disease
07/17/2007US7244818 Interferon alpha responsive protein
07/17/2007US7244817 Pro1357 polypeptide
07/17/2007US7244615 Producing an antibody comprising complementarity determining regions, heavy and light chains, and non-human donor residues, a variable domain; used for in vivo therapy and diagnosis
07/17/2007US7244613 Expression vector comprising nucleotide sequences coding tubercular complex for use in developing vaccines for treatment and prevention of respiratory system disorders; bactericides
07/17/2007US7244604 HDAC9 polypeptides and polynucleotides and uses thereof
07/17/2007US7244599 Gene and uses therefor to modify pasture qualities of crops
07/17/2007US7244592 Identifying immunoglobulins for use as therapeutic, diagnostic an/or affinity separation agents; in vitro translation
07/17/2007US7244587 Expression vectors encoding bacteriophage signal peptides
07/17/2007US7244580 Immunogenic composition for use in the diagnosis of allergies in mammals
07/17/2007US7244574 reacts with prothrombin forming a complex with phosphatidylserine (PS/PT) but does not react with prothrombin (PT) not forming a complex with phosphatidylserine
07/17/2007US7244429 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof
07/17/2007US7244428 PRO1357 antibodies
07/17/2007US7244427 Isolated bovine IgG heavy chain protein and its use as an antimicrobial
07/17/2007CA2182013C Humanized antibodies against leukocyte adhesion molecule vla-4
07/12/2007WO2007079218A2 Metalloproteinase binding proteins
07/12/2007WO2007078202A1 Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (nait)
07/12/2007WO2007077934A1 Anti-periostin antibody and pharmaceutical composition for preventing or treating periostin-related disease containing the same
07/12/2007WO2007077464A2 Chicken virus vaccine and diagnostic
07/12/2007WO2007077365A2 IMMUNOGLOBULIN G (IgG) CONCENTRATE DEPLETED OF ANTI-A AND ANTI-B ANTIBODIES AND OF POLYREACTIVE IgGs
07/12/2007WO2007077261A1 New method for the treatment of gout or pseudogout
07/12/2007WO2007077173A1 Antibody molecules specific for fibroblast activation protein and immunoconjugates containing them
07/12/2007WO2007077042A1 New method for the treatment of gout or pseudogout
07/12/2007WO2007076950A1 Anti-cd19 antibodies with reduced immunogenicity
07/12/2007WO2007076927A1 Anti-il-6 antibodies preventing the binding of il-6 complexed with il-6ralpha to gp130
07/12/2007WO2007044616A3 Optimized anti-cd30 antibodies
07/12/2007WO2007039184A3 Method and analytical reagents for identifying therapeutics using biomarkers responsive to thiazolidinediones
07/12/2007WO2007024249A3 Engineering fc antibody regions to confer effector function
07/12/2007WO2007019541A3 Antibody compositions, methods for treating neoplastic disease and methods for regulating fertility
07/12/2007WO2007016542A3 Her-2 blocking bifunctional targeted peptides
07/12/2007WO2007007159A3 Anti-madcam antibodies to treat uterine disorders
07/12/2007WO2007005948A3 Methods and compositions for diagnosis and treatment of viral and bacterial infections
07/12/2007WO2007005605A3 Phosphospecific chemokine receptor antibodies
07/12/2007WO2007002261A3 IL-1β BINDING ANTIBODIES AND FRAGMENTS THEREOF
07/12/2007WO2006105343A3 Dkkl-i splice product modulators for cancer diagnosis and therapy
07/12/2007WO2006096653A3 Methods of humanizing immunoglobulin variable regions through rational modification of complementarity determining residues
07/12/2007WO2006096451A3 Methionine sulfoxide antibodies
07/12/2007WO2006039638A3 Treating renal cell carcinoma with an anti-tnf human antibody or fragment
07/12/2007WO2006031928A3 Arf-bp1 as mediator of p53-dependent and independent tumor suppression and uses thereof
07/12/2007WO2005123126A3 Antibodies against human interleukin-13 and uses therefor
07/12/2007WO2005120569A3 Improved therapeutic agent for inos generating illness
07/12/2007WO2005097184A3 Antibodies against nogo receptor
07/12/2007WO2005019409A3 Combinatorial protein library screening by periplasmic expression
07/12/2007WO2003102136A3 Antibodies that specifically bind to neurokinin b
07/12/2007US20070161783 Optimized proteins that target Ep-CAM
07/12/2007US20070161782 Peptides for Detection of Antibody to Ehrlichia ewingii
07/12/2007US20070161604 urinary diseases, central nervous diseases, inflammatory diseases, circulatory diseases, cancer, diabetes, immune system disorders and alimentary diseases
07/12/2007US20070161586 Drug for preventing and treating atherosclerosis
07/12/2007US20070161099 Methods for using polypeptides having amylase activity and nucleic acids encoding them
07/12/2007US20070161089 Method of Producing Pan-Specific Antibodies
07/12/2007US20070161080 Antibodies
07/12/2007US20070161066 Immunoglobulin E detection in mammalian species
07/12/2007US20070161061 Novel composition and methods for the treatment of immune related diseases
07/12/2007US20070161059 N1,n12-diacetylspermine as tumor marker
07/12/2007US20070161050 Monoclonal antibodies to mesenchymal stem cells
07/12/2007US20070161048 Anti nc1 monoclonal antibody
07/12/2007US20070161046 Truncated aggrecanase molecules
07/12/2007US20070161041 Identification of feline or canine probnp
07/12/2007US20070161040 Hybrid proteins of active-site serine beta-lactamase
07/12/2007US20070161021 Novel nucleic acids and polypeptides related to a guanine exchange factor of Rho GTPase
07/12/2007US20070160993 Novel centromeric protein shugoshin